Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Regenerative Medicine: The Next Frontier for Big Pharma
Nov 17, 2008 12:19 PM
- Who Will Replace GM In The Dow?
Nov 11, 2008 10:24 AM
- The Week In Review: More Fallout From Economic Crisis
Nov 09, 2008 02:00 PM
- The Bear’s Case For Genentech
Nov 07, 2008 11:42 AM
- The Bull’s Case For Genentech
Nov 03, 2008 11:59 AM
- Picking Some Stocks To Survive The Market
Oct 19, 2008 08:09 PM
- UK Limits Quality of Life Drugs To £30,000 Per Year
Oct 11, 2008 09:15 PM
- Roche's Xeloda Approved in China for Gastric Cancer
Sep 02, 2008 03:46 PM
- Genentech Inc: Roche Buyout at $113 to $118
Aug 19, 2008 12:06 PM
- Periodicals Wrap-Up for Monday, July 21st
Jul 21, 2008 09:54 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
RHHBY
|
Compare to S&P
|
| YTD |
-18.38 %
|
33.72 %
|
| 4 Weeks |
-8.05 %
|
-0.61 %
|
| 12 Weeks |
-15.26 %
|
17.46 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
